• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

带状疱疹的预防:带状疱疹活疫苗的安全性和有效性。

Prevention of shingles: safety and efficacy of live zoster vaccine.

出版信息

Ther Clin Risk Manag. 2007 Aug;3(4):633-9.

PMID:18472986
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2374947/
Abstract

Primary infection with varicella zoster virus (VZV) causes chickenpox (varicella) after which virus becomes latent in cranial nerve, dorsal root and autonomic ganglia along the entire neuraxis. Virus may later reactivate, causing shingles (zoster), characterized by pain and rash restricted to 1-3 dermatomes. More than 40% of zoster patients over age 60 develop postherpetic neuralgia (PHN), pain that persists for months to years. The socioeconomic impact of primary varicella infection has been lessened by introduction of VZV vaccine for children. However, the effect of childhood vaccination on the incidence of zoster is unknown. Virus reactivation correlates with waning cell-mediated immunity (CMI) to VZV with normal aging. Adults exposed to children with varicella may have a boost in CMI to VZV. For at least several more decades, the incidence of zoster may increase as the elderly population grows. The anticipated increase in zoster burden of illness in future decades was a major impetus for the Shingles Prevention Study, a prospective, double-blind, placebo-controlled trial of attenuated VZV vaccine to prevent zoster in older adults. This review discusses clinical and virological aspects of zoster and its complications, current treatment options, and VZV vaccine development along with its future role in disease prevention.

摘要

初次感染水痘带状疱疹病毒(VZV)后会引发水痘(带状疱疹),此后病毒会潜伏在颅神经、脊神经根和自主神经节中,沿整个脊神经轴分布。病毒随后可能会重新激活,导致带状疱疹(带状疱疹),其特征是疼痛和皮疹局限于 1-3 个皮节。60 岁以上的带状疱疹患者中有超过 40%会出现带状疱疹后神经痛(PHN),这种疼痛会持续数月甚至数年。由于儿童接种了 VZV 疫苗,原发性水痘感染的社会经济影响已经减轻。然而,儿童接种疫苗对带状疱疹发病率的影响尚不清楚。病毒的重新激活与细胞介导免疫(CMI)对 VZV 的减弱有关,这是随着年龄的正常衰老而发生的。接触有水痘儿童的成年人可能会增强对 VZV 的 CMI。至少在未来几十年内,随着老年人口的增加,带状疱疹的发病率可能会增加。未来几十年带状疱疹疾病负担的预期增加是带状疱疹预防研究的主要动力,这是一项针对老年人的、前瞻性的、双盲的、安慰剂对照的减毒 VZV 疫苗预防带状疱疹的临床试验。这篇综述讨论了带状疱疹及其并发症的临床和病毒学方面、当前的治疗选择以及 VZV 疫苗的开发,以及它在疾病预防中的未来作用。

相似文献

1
Prevention of shingles: safety and efficacy of live zoster vaccine.带状疱疹的预防:带状疱疹活疫苗的安全性和有效性。
Ther Clin Risk Manag. 2007 Aug;3(4):633-9.
2
Review: The neurobiology of varicella zoster virus infection.综述:水痘-带状疱疹病毒感染的神经生物学。
Neuropathol Appl Neurobiol. 2011 Aug;37(5):441-63. doi: 10.1111/j.1365-2990.2011.01167.x.
3
Varicella zoster virus latency, neurological disease and experimental models: an update.水痘带状疱疹病毒潜伏、神经系统疾病与实验模型:最新进展
Front Biosci. 2004 Jan 1;9:751-62. doi: 10.2741/1275.
4
Clinical and molecular pathogenesis of varicella virus infection.水痘病毒感染的临床与分子发病机制
Viral Immunol. 2003;16(3):243-58. doi: 10.1089/088282403322396073.
5
Herpes zoster pathogenesis and cell-mediated immunity and immunosenescence.带状疱疹的发病机制、细胞介导免疫与免疫衰老
J Am Osteopath Assoc. 2009 Jun;109(6 Suppl 2):S13-7.
6
Varicella virus-mononuclear cell interaction.水痘病毒-单核细胞相互作用
Adv Virus Res. 2003;62:1-17. doi: 10.1016/s0065-3527(03)62001-4.
7
The variegate neurological manifestations of varicella zoster virus infection.水痘-带状疱疹病毒感染的多样神经表现。
Curr Neurol Neurosci Rep. 2013 Sep;13(9):374. doi: 10.1007/s11910-013-0374-z.
8
Varicella Zoster Virus in the Nervous System.神经系统中的水痘带状疱疹病毒
F1000Res. 2015 Nov 26;4. doi: 10.12688/f1000research.7153.1. eCollection 2015.
9
Advances in the treatment of varicella-zoster virus infections.水痘-带状疱疹病毒感染的治疗进展
Adv Pharmacol. 2013;67:107-68. doi: 10.1016/B978-0-12-405880-4.00004-4.
10
Prevention strategies: herpes zoster, post-herpetic neuralgia and immunogenicity.预防策略:带状疱疹、带状疱疹后神经痛及免疫原性。
Herpes. 2007 Sep;14 Suppl 2:45-7.

本文引用的文献

1
Comparison of virus transcription during lytic infection of the Oka parental and vaccine strains of Varicella-Zoster virus.水痘-带状疱疹病毒Oka亲本株和疫苗株溶细胞感染期间病毒转录的比较。
J Virol. 2006 Mar;80(5):2076-82. doi: 10.1128/JVI.80.5.2076-2082.2006.
2
Varicella immunization and herpes zoster.水痘免疫接种与带状疱疹
Herpes. 2005 Dec;12(3):59.
3
Modelling the impact of vaccination on the epidemiology of varicella zoster virus in Australia.模拟疫苗接种对澳大利亚水痘带状疱疹病毒流行病学的影响。
Aust N Z J Public Health. 2005 Dec;29(6):544-51. doi: 10.1111/j.1467-842x.2005.tb00248.x.
4
New viral vaccines.新型病毒疫苗。
Virology. 2006 Jan 5;344(1):240-9. doi: 10.1016/j.virol.2005.09.057.
5
The burden of Herpes Zoster: a prospective population based study.带状疱疹的负担:一项基于人群的前瞻性研究。
Vaccine. 2006 Feb 27;24(9):1308-14. doi: 10.1016/j.vaccine.2005.09.026. Epub 2005 Sep 30.
6
A single dose of gabapentin reduces acute pain and allodynia in patients with herpes zoster.单剂量加巴喷丁可减轻带状疱疹患者的急性疼痛和痛觉过敏。
Neurology. 2005 Aug 9;65(3):444-7. doi: 10.1212/01.wnl.0000168259.94991.8a.
7
The incidence of herpes zoster in a United States administrative database.美国一个行政数据库中带状疱疹的发病率。
J Gen Intern Med. 2005 Aug;20(8):748-53. doi: 10.1111/j.1525-1497.2005.0150.x.
8
Pain, medication use, and health-related quality of life in older persons with postherpetic neuralgia: results from a population-based survey.老年带状疱疹后神经痛患者的疼痛、药物使用及健康相关生活质量:一项基于人群的调查结果
J Pain. 2005 Jun;6(6):356-63. doi: 10.1016/j.jpain.2005.01.359.
9
Varicella-zoster virus vaccine--grown-ups need it, too.水痘带状疱疹病毒疫苗——成年人也需要它。
N Engl J Med. 2005 Jun 2;352(22):2344-6. doi: 10.1056/NEJMe058090.
10
A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.一种预防老年人带状疱疹及带状疱疹后神经痛的疫苗。
N Engl J Med. 2005 Jun 2;352(22):2271-84. doi: 10.1056/NEJMoa051016.